News

The first FDA-approved device to reduce functional abdominal pain in younger patients with irritable bowel syndrome is now available to medical providers.

The service is designed to help CVS Caremark PBM clients more easily contract, implement, and manage their choice of available and emerging third-party health and wellness benefit solutions.

As healthcare becomes more patient-centric, can healthcare technology keep up?

What the move could mean for patient outcomes.

A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.

Being a CEO can be a fulfilling-yet demanding-role. Here are 12 stress-busters that promote self-care.

Enrollment impacts an MAO’s revenue and profitability and is a key driver to becoming successful. Here are ways to better understand enrollment potential for new organizations.

New study finds that SDOH can affect cardiac health.

With Anthem’s announcement that it will acquire Beacon Health Options, analysts say it makes for insurers to get more into mental healthcare.

The rare disease community struggles to balance care with costs.

While aggressive early intervention may be useful for diabetes patients, that intervention must be sustained.

How healthcare executives can develop a deep understanding of the patient populations they serve.

These are the important policies to watch out for in 2019.

The first step in helping consumers navigate the cost of care is to provide them with a basic understanding of what healthcare services actually cost.

CMS introduced indication-based formularies as a voluntary tool for plans to implement in 2020.

A new survey has surprising results about the one issue that keeps hospital and healthcare executives awake at night.

A new report found that OCM practices have a harder time achieving benchmarks than predicted.

Why Medicare Advantage isn’t as popular for first-year Medicare beneficiaries.

Are accelerated approvals having as much impact as the FDA hopes?

New research reveals that women are excelling in the field. Why this is good news for the C-suite.

FDA cleared the first-and-only calcitonin gene-related peptide (CGRP) antibody for cluster headaches.

How relational tension in the OR can affect patient outcomes.

Why health executives need to pay attention to mobile options.

A new study has revealing findings about the effects of front-end opioid prescribing for knee, hip, and shoulder joint replacement patients.

The first respiratory biologic to be approved for administration via an autoinjector will be available in the US soon.

Managed Healthcare Executive asked 17 key opinion leaders, “Who is Your Healthcare ‘Hero’ and why? Here’s what they said.

How to manage drug cost in a value-based world.

Expert recommendations on new leadership skills speak to both external market forces as well as internal fundamentals.